Funded startups/Aethl Bio, Inc.
AB

Aethl Bio, Inc.

SEC filing
Biotechnology · Pittsburgh, PA
Form D on EDGAR
Amount raised$1.6Msold at filing
Total offering$5M$3.4M still open
Investors in the raise8count reported to the SEC
FiledApr 17, 2026first sale Jul 14, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Zachary RichertDirector
Melissa ThompsonExecutive Officer
Carmelo MontalvoExecutive Officer, Director
Dan WillisExecutive Officer

Executive officers, directors and promoters as listed on the Form D.